SAN DIEGO, CA / ACCESSWIRE / December 13, 2024 / (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing ("POCT") ...

Why does the COVID-19 virus make some people sicker than others? For years, scientists have looked to a critical piece of ...

M icrobiologists have studied bacterial defense mechanisms against phages for decades. But until less than a decade ago, ...

For years, scientists have looked to a critical piece of immune system machinery - known as the interferon pathway - for answers. There, when our cells sense an infection, they release a protein known ...

Researchers have discovered a protein variant that serves as a knob for regulating the body's innate immune response. The findings could lead to new therapies for Long COVID, autoimmune disorders, and ...

Why does the COVID-19 virus make some people sicker than others? For years, scientists have looked to a critical piece of ...

PolyPid (PYPD) announced a new research and development collaboration with ImmunoGenesis, a Houston-based clinical-stage ...

Aligos Therapeutics focuses on ALG-000184 for CHB and ALG-055009 for MASH, targeting large, underserved markets with growing ...

Zwygart AC, Medaglia C, Zhu Y, Bart Tarbet E, Jonna W, Fage C, Le Roy D, Roger T, Clément S, Constant S, Huang S, Stellacci F, Silva PJ, Tapparel C. Development of Broad-Spectrum β-Cyclodextrins-Based ...

Request To Download Free Sample of This Strategic Report @ The publisher has been vigilantly tracking the diverse markets within Saudi Arabia. This report presents an extensive analysis, encompassing ...

Researchers have shown how genetic defects in Toxoplasma gondii are rescued if co-infected with normal parasites, thanks to ...

Median OS increased from 11 to 13 months in IMNN-001 treatment group based on latest data analysis No change in IMNN-001 favorable safety profile including no reports of serious immune-related adverse ...